索塔洛尔用于治疗胎儿节律失常症
M A Oudijk1, M M Michon, C S Kleinman
1Department of Obstetrics, University Medical Center, Utrecht, the Netherlands.
Circulation
|June 14, 2000
概括
移植性索塔洛尔有效治疗胎儿心房动 (AF),但有胎儿心房动 (SVT) 的风险. 治疗的开始至关重要,特别是在hydrops fetalis,但要仔细考虑sotalol的使用.
科学领域:
- 心脏病学 心脏病学
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胎儿低心率可能导致胎儿水和胎儿死亡.
- 胎儿高心率的最佳治疗策略仍在争论中.
- 移植性索塔醇疗法被评估为安全性和有效性.
研究的目的:
- 评估移植性索塔醇在治疗胎儿心跳动的安全性和有效性.
- 为了确定不同类型的胎儿心律失常症中索塔的有效性.
- 评估索塔在治疗胎儿心动减速症中的风险和益处.
主要方法:
- 对21名患者的回顾性评估,这些患者在胎儿心动减速时接受了索塔醇治疗.
- 对胎儿状况的分析,包括心房动 (AF),心室上动 (SVT) 和心室内动 (VT).
- 评估治疗成功,死亡率和产后结果.
主要成果:
- 索塔洛尔成功地在80%患有AF的胎儿和60%患有SVT的胎儿中建立了鼻节律.
- 观察到19%的死亡率 (4/21胎儿),在SVT组中有3例死亡.
- 在子宫转化后,在2名产后婴儿中观察到神经病理.
结论:
- 胎儿低心率需要及时治疗,特别是当胎儿液存在时.
- 索塔洛尔是胎儿心房的潜在首选治疗方法,因为其成功率很高.
- 索塔洛尔的风险可能会超过胎儿SVT的益处,这表明在这种情况下使用限制.
相关概念视频
Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.4K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.4K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
2.9K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
Heart Failure Drugs: Inotropic Agents
2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
Dysrhythmias VI: Management of Dysrhythmias
599
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
599
Dysrhythmias VII: Nursing Management of Dysrhythmias
510
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
510
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
1.2K
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.2K


